1. Home
  2. ARQT vs PATK Comparison

ARQT vs PATK Comparison

Compare ARQT & PATK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • PATK
  • Stock Information
  • Founded
  • ARQT 2016
  • PATK 1959
  • Country
  • ARQT United States
  • PATK United States
  • Employees
  • ARQT N/A
  • PATK N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • PATK Auto Parts:O.E.M.
  • Sector
  • ARQT Health Care
  • PATK Consumer Discretionary
  • Exchange
  • ARQT Nasdaq
  • PATK Nasdaq
  • Market Cap
  • ARQT 3.3B
  • PATK 3.4B
  • IPO Year
  • ARQT 2020
  • PATK N/A
  • Fundamental
  • Price
  • ARQT $28.01
  • PATK $98.50
  • Analyst Decision
  • ARQT Strong Buy
  • PATK Buy
  • Analyst Count
  • ARQT 7
  • PATK 9
  • Target Price
  • ARQT $22.17
  • PATK $105.78
  • AVG Volume (30 Days)
  • ARQT 3.1M
  • PATK 287.4K
  • Earning Date
  • ARQT 10-28-2025
  • PATK 10-30-2025
  • Dividend Yield
  • ARQT N/A
  • PATK 1.63%
  • EPS Growth
  • ARQT N/A
  • PATK N/A
  • EPS
  • ARQT N/A
  • PATK 3.51
  • Revenue
  • ARQT $317,929,000.00
  • PATK $3,872,728,000.00
  • Revenue This Year
  • ARQT $85.27
  • PATK $5.69
  • Revenue Next Year
  • ARQT $30.70
  • PATK $5.35
  • P/E Ratio
  • ARQT N/A
  • PATK $28.04
  • Revenue Growth
  • ARQT 129.21
  • PATK 6.08
  • 52 Week Low
  • ARQT $9.19
  • PATK $72.99
  • 52 Week High
  • ARQT $28.96
  • PATK $116.78
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 71.06
  • PATK 41.04
  • Support Level
  • ARQT $22.26
  • PATK $95.25
  • Resistance Level
  • ARQT $24.39
  • PATK $106.58
  • Average True Range (ATR)
  • ARQT 1.46
  • PATK 3.16
  • MACD
  • ARQT 0.21
  • PATK -0.71
  • Stochastic Oscillator
  • ARQT 85.67
  • PATK 26.35

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About PATK Patrick Industries Inc.

Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.

Share on Social Networks: